BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Opron K, Begley LA, Erb-Downward JR, Freeman C, Madapoosi S, Alexis NE, Barjaktarevic I, Graham Barr R, Bleecker ER, Bowler RP, Christenson SA, Comellas AP, Cooper CB, Couper DJ, Doerschuk CM, Dransfield MT, Han MK, Hansel NN, Hastie AT, Hoffman EA, Kaner RJ, Krishnan J, O'Neal WK, Ortega VE, Paine R 3rd, Peters SP, Michael Wells J, Woodruff PG, Martinez FJ, Curtis JL, Huffnagle GB, Huang YJ. Lung microbiota associations with clinical features of COPD in the SPIROMICS cohort. NPJ Biofilms Microbiomes 2021;7:14. [PMID: 33547327 DOI: 10.1038/s41522-021-00185-9] [Cited by in Crossref: 14] [Cited by in F6Publishing: 18] [Article Influence: 14.0] [Reference Citation Analysis]
Number Citing Articles
1 Natalini JG, Singh S, Segal LN. The dynamic lung microbiome in health and disease. Nat Rev Microbiol 2022. [DOI: 10.1038/s41579-022-00821-x] [Reference Citation Analysis]
2 Begley LA, Opron K, Bian G, Kozik AJ, Liu C, Felton J, Wen B, Sun D, Huang YJ. Effects of Fluticasone Propionate on Klebsiella pneumoniae and Gram-Negative Bacteria Associated with Chronic Airway Disease. mSphere 2022. [DOI: 10.1128/msphere.00377-22] [Reference Citation Analysis]
3 Keir HR, Chalmers JD. Rebuttal From Dr Keir and Prof Chalmers. Chest 2022;162:977-978. [DOI: 10.1016/j.chest.2022.07.012] [Reference Citation Analysis]
4 Keir HR, Chalmers JD. COUNTERPOINT: Is Chronic Bacterial Infection Clinically Relevant in COPD? No. Chest 2022;162:972-976. [DOI: 10.1016/j.chest.2022.07.009] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 De Nuccio F, Piscitelli P, Toraldo DM. Gut-lung Microbiota Interactions in Chronic Obstructive Pulmonary Disease (COPD): Potential Mechanisms Driving Progression to COPD and Epidemiological Data. Lung 2022. [PMID: 36241745 DOI: 10.1007/s00408-022-00581-8] [Reference Citation Analysis]
6 Yin M, Gao Y, Shang J, Zheng C, Liu J. Multi-similarity fusion-based label propagation for predicting microbes potentially associated with diseases. Future Generation Computer Systems 2022;134:247-55. [DOI: 10.1016/j.future.2022.04.012] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
7 Russo C, Colaianni V, Ielo G, Valle MS, Spicuzza L, Malaguarnera L. Impact of Lung Microbiota on COPD. Biomedicines 2022;10:1337. [DOI: 10.3390/biomedicines10061337] [Reference Citation Analysis]
8 Christenson SA, Smith BM, Bafadhel M, Putcha N. Chronic obstructive pulmonary disease. The Lancet 2022. [DOI: 10.1016/s0140-6736(22)00470-6] [Cited by in Crossref: 12] [Cited by in F6Publishing: 18] [Article Influence: 12.0] [Reference Citation Analysis]
9 Love ME, Proud D. Respiratory Viral and Bacterial Exacerbations of COPD—The Role of the Airway Epithelium. Cells 2022;11:1416. [DOI: 10.3390/cells11091416] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Wang Y, Chen Y, Wu C, Yang X. Informatic analysis of the pulmonary microecology in non-cystic fibrosis bronchiectasis at three different stages. Open Life Sciences 2022;17:107-20. [DOI: 10.1515/biol-2022-0014] [Reference Citation Analysis]
11 Erb-downward JR. Concepts, Tools, and Methodologic Considerations for Lung Microbiome Research. The Microbiome in Respiratory Disease 2022. [DOI: 10.1007/978-3-030-87104-8_2] [Reference Citation Analysis]
12 Xiang L, Meng X. Emerging cellular and molecular interactions between the lung microbiota and lung diseases. Crit Rev Microbiol 2021;:1-34. [PMID: 34693852 DOI: 10.1080/1040841X.2021.1992345] [Reference Citation Analysis]
13 Keir HR, Contoli M, Chalmers JD. Inhaled Corticosteroids and the Lung Microbiome in COPD. Biomedicines 2021;9:1312. [PMID: 34680429 DOI: 10.3390/biomedicines9101312] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 5.0] [Reference Citation Analysis]
14 Whiteside SA, McGinniss JE, Collman RG. The lung microbiome: progress and promise. J Clin Invest 2021;131:150473. [PMID: 34338230 DOI: 10.1172/JCI150473] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 11.0] [Reference Citation Analysis]
15 Seixas S, Kolbe AR, Gomes S, Sucena M, Sousa C, Vaz Rodrigues L, Teixeira G, Pinto P, Tavares de Abreu T, Bárbara C, Semedo J, Mota L, Carvalho AS, Matthiesen R, Marques PI, Pérez-Losada M. Comparative analysis of the bronchoalveolar microbiome in Portuguese patients with different chronic lung disorders. Sci Rep 2021;11:15042. [PMID: 34294826 DOI: 10.1038/s41598-021-94468-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
16 Healy C, Munoz-Wolf N, Strydom J, Faherty L, Williams NC, Kenny S, Donnelly SC, Cloonan SM. Nutritional immunity: the impact of metals on lung immune cells and the airway microbiome during chronic respiratory disease. Respir Res 2021;22:133. [PMID: 33926483 DOI: 10.1186/s12931-021-01722-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 15] [Article Influence: 13.0] [Reference Citation Analysis]